Tag: revance therapeutics

All

Revance Reports Q4 and Full Year 2021 Financial Results; Credits Dermal Filler Sales for Growth

The company also announced progress on its DaxibotulinumtoxinA for Injection for glabellar lines and intent to launch the RHA Redensity dermal filler in the second half of 2022.

Revance Resubmits BLA to FDA for DaxibotulinumtoxinA for Injection
Revance Closes on $300M Note Purchase Agreement with Athyrium Capital Management
FDA Accepts Revance Resubmission for Frown Line Treatment
FDA Approves Revance Daxxify for Frown Lines
Studies Show Efficacy of Daxxify to Treat Frown Lines
Revance Publishes 2 Papers on Daxxify Injectable
Crown Laboratories Acquires Revance Therapeutics, Expanding Aesthetic Portfolio

All

Sorry, No Posts Found

All

Dual Argon and Nitrogen Gas Plasma System Now Available in North America

The non-surgical platform is designed for a range of aesthetic concerns including texture refinement, tone correction, and skin tightening.

Cutera Announces New Global Initiative Celebrating Laser Aesthetics
FDA Warns of Serious Complications with Certain RF Microneedling Devices
Long-Term Study Shows Positive Outcomes for Bioresorbable Breast Scaffold After Lumpectomy

Tag: revance therapeutics

All

Revance Reports Q4 and Full Year 2021 Financial Results; Credits Dermal Filler Sales for Growth

Revance Resubmits BLA to FDA for DaxibotulinumtoxinA for Injection

Revance Closes on $300M Note Purchase Agreement with Athyrium Capital Management

FDA Accepts Revance Resubmission for Frown Line Treatment

FDA Approves Revance Daxxify for Frown Lines

Studies Show Efficacy of Daxxify to Treat Frown Lines

Revance Publishes 2 Papers on Daxxify Injectable

Crown Laboratories Acquires Revance Therapeutics, Expanding Aesthetic Portfolio

All

Sorry, No Posts Found

All

Dual Argon and Nitrogen Gas Plasma System Now Available in North America

Cutera Announces New Global Initiative Celebrating Laser Aesthetics

FDA Warns of Serious Complications with Certain RF Microneedling Devices

Long-Term Study Shows Positive Outcomes for Bioresorbable Breast Scaffold After Lumpectomy

Sorry, No Posts Found

Plastic Surgery Practice

Our Parent Company

Key Resources

Helpful Links